These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34511240)

  • 1. Outcomes after targeted treatment based on somatic tumor genetic testing for women with gynecologic cancers.
    Somasegar S; Hoppenot C; Kuchta K; Sereika A; Khandekar J; Rodriguez G; Moore E; Hurteau J; Vogel TJ
    Gynecol Oncol; 2021 Nov; 163(2):220-228. PubMed ID: 34511240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation sequencing for gynecologic malignancy: Promise and potential pitfalls.
    Hinchcliff EM; Westin SN
    Gynecol Oncol; 2021 Nov; 163(2):217-219. PubMed ID: 34756289
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular Profiling and Targeted Therapy in Cholangiocarcinoma: An Observational, Retrospective Multicenter Study.
    Garcia-Pardo M; Ortega L; Fernández-Aceñero MJ; García Alfonso P; Martín M; Muñoz AJ
    J Gastrointest Cancer; 2021 Jun; 52(2):814-818. PubMed ID: 33683644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized Medicine in Gynecologic Cancer: Fact or Fiction?
    Corey L; Valente A; Wade K
    Surg Oncol Clin N Am; 2020 Jan; 29(1):105-113. PubMed ID: 31757307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of somatic molecular profiling on clinical trial outcomes in rare epithelial gynecologic cancer patients.
    Rodriguez-Freixinos V; Lheureux S; Mandilaras V; Clarke B; Dhani NC; Mackay H; Butler MO; Wang L; Siu LL; Kamel-Reid S; Stockley T; Bedard PL; Oza AM
    Gynecol Oncol; 2019 May; 153(2):304-311. PubMed ID: 30792002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Molecular Analysis in Adrenocortical Carcinomas: A Strategy Toward Improved Personalized Prognostication.
    Lippert J; Appenzeller S; Liang R; Sbiera S; Kircher S; Altieri B; Nanda I; Weigand I; Gehrig A; Steinhauer S; Riemens RJM; Rosenwald A; Müller CR; Kroiss M; Rost S; Fassnacht M; Ronchi CL
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4511-4523. PubMed ID: 30113656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of molecular testing in clinical practice in gynecologic cancers.
    Huang M; Hunter T; Slomovitz B; Schlumbrecht M
    Cancer Med; 2019 May; 8(5):2013-2019. PubMed ID: 30848097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actionable molecular alterations in advanced gynaecologic malignancies: updated results from the ProfiLER programme.
    Varnier R; Le Saux O; Chabaud S; Garin G; Sohier E; Wang Q; Paindavoine S; Pérol D; Baudet C; Attignon V; Pissaloux D; Heudel P; You B; Leyronnas C; Collard O; Trédan O; Bonnin N; Long J; Jacquin JP; Cassier PA; Derbel O; Freyer G; Viari A; Blay JY; Ray-Coquard I
    Eur J Cancer; 2019 Sep; 118():156-165. PubMed ID: 31351267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from Therapy.
    Kang H; Pettinga D; Schubert AD; Ladenson PW; Ball DW; Chung JH; Schrock AB; Madison R; Frampton GM; Stephens PJ; Ross JS; Miller VA; Ali SM
    Oncologist; 2019 Jun; 24(6):791-797. PubMed ID: 30373905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of actionable genetic alterations with targeted panel sequencing in children with relapsed or refractory solid tumors.
    Lee JW; Kim NKD; Lee SH; Cho HW; Ma Y; Ju HY; Yoo KH; Sung KW; Koo HH; Park WY
    PLoS One; 2019; 14(11):e0224227. PubMed ID: 31747416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
    Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Guided Treatments in Gynecologic Oncology: Analysis of a Real-World Precision Cancer Medicine Platform.
    Taghizadeh H; Mader RM; Müllauer L; Aust S; Polterauer S; Kölbl H; Seebacher V; Grimm C; Reinthaller A; Prager GW
    Oncologist; 2020 Jul; 25(7):e1060-e1069. PubMed ID: 32369643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An institutional review of genomic sequencing in pediatric solid tumors.
    Turco GM; Gupta A; Monteleone P; Kelly KM; Klein RD; Wiltsie L; Barth M
    Pediatr Blood Cancer; 2023 Jun; 70(6):e30324. PubMed ID: 37017066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers.
    Pereira E; Camacho-Vanegas O; Anand S; Sebra R; Catalina Camacho S; Garnar-Wortzel L; Nair N; Moshier E; Wooten M; Uzilov A; Chen R; Prasad-Hayes M; Zakashansky K; Beddoe AM; Schadt E; Dottino P; Martignetti JA
    PLoS One; 2015; 10(12):e0145754. PubMed ID: 26717006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular profiling of gynecologic cancers for treatment and management of disease - demonstrating clinical significance using the AMP/ASCO/CAP guidelines for interpretation and reporting of somatic variants.
    Nie Q; Omerza G; Chandok H; Prego M; Hsiao MC; Meyers B; Hesse A; Uvalic J; Soucy M; Bergeron D; Peracchio M; Burns S; Kelly K; Rowe S; Rueter J; Reddi HV
    Cancer Genet; 2020 Apr; 242():25-34. PubMed ID: 31992506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving Significance of Tumor-Normal Sequencing in Cancer Care.
    Mandelker D; Ceyhan-Birsoy O
    Trends Cancer; 2020 Jan; 6(1):31-39. PubMed ID: 31952779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-World Data From a Molecular Tumor Board: Improved Outcomes in Breast and Gynecologic Cancers Patients With Precision Medicine.
    Charo LM; Eskander RN; Sicklick J; Kim KH; Lim HJ; Okamura R; Lee S; Subramanian R; Schwab R; Shatsky R; Plaxe S; Kato S; Kurzrock R
    JCO Precis Oncol; 2022 Jan; 6():e2000508. PubMed ID: 35005995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Utility of Next-Generation Sequencing in Advanced Breast and Gynecologic Cancers.
    Jones TE; Zou J; Tseng GC; Roy S; Bhargava R
    Am J Clin Pathol; 2021 Aug; 156(3):455-460. PubMed ID: 33728425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining If a Somatic Tumor Mutation Is Targetable and Options for Accessing Targeted Therapies.
    Bruinooge SS; Sherwood S; Grubbs S; Schilsky RL
    J Oncol Pract; 2019 Nov; 15(11):575-583. PubMed ID: 31386607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Tumor Boards in Clinical Practice.
    Luchini C; Lawlor RT; Milella M; Scarpa A
    Trends Cancer; 2020 Sep; 6(9):738-744. PubMed ID: 32517959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.